Compare UBCP & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UBCP | ADAG |
|---|---|---|
| Founded | 1902 | 2011 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 78.4M | 90.5M |
| IPO Year | N/A | 2021 |
| Metric | UBCP | ADAG |
|---|---|---|
| Price | $13.85 | $2.02 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 4.3K | ★ 42.9K |
| Earning Date | 02-06-2026 | 08-12-2025 |
| Dividend Yield | ★ 6.88% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.31 | N/A |
| Revenue | ★ $30,516,000.00 | $103,204.00 |
| Revenue This Year | N/A | $4,446.34 |
| Revenue Next Year | $5.59 | $30.43 |
| P/E Ratio | $10.37 | ★ N/A |
| Revenue Growth | ★ 4.40 | N/A |
| 52 Week Low | $12.25 | $1.30 |
| 52 Week High | $15.64 | $3.16 |
| Indicator | UBCP | ADAG |
|---|---|---|
| Relative Strength Index (RSI) | 48.00 | 57.08 |
| Support Level | $13.55 | $1.69 |
| Resistance Level | $13.98 | $1.98 |
| Average True Range (ATR) | 0.35 | 0.15 |
| MACD | -0.11 | 0.02 |
| Stochastic Oscillator | 31.02 | 89.81 |
United Bancorp Inc operates as a bank holding company that provides commercial and retail banking services. Through its subsidiary (Unified Bank), the company provides a broad range of banking and financial services, which includes accepting demand, savings, and time deposits and granting commercial, real estate, and consumer loans. It serves customers in Belmont, Harrison, Jefferson, Tuscarawas, Carroll, Athens, Hocking, and Fairfield counties and the surrounding localities. The bank also operates in Marshall County West Virginia.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.